Shining Bright: Phototherapy Treatment Market Set to Illuminate with a 5% CAGR, Surging to US$ 675 Million by 2026

The Phototherapy Treatment Market is slated to reach US$ 530 Million by 2022-end and is further expected to surge at a value CAGR of 5% until 2026. A closing valuation worth US$ 675 Million is anticipated for the market by 2026. Acne is one of the most prevalent skin conditions among teenagers in the United States. While topical or oral antibiotics continue to be the primary form of care, more sophisticated medicines may be considered if the illness worsens. Both doctors and patients are quite concerned about Propionibacterium acnes’ rising resistance to common medicines. As a result, doctors must take into account alternative therapy modalities that can produce speedier and more effective effects.

A successful and modern treatment option for psoriasis and acne, which is enjoying recent growth in popularity, is phototherapy. Phototherapy is more inexpensive than biologics while maintaining a similar level of credibility. It is anticipated that the demand for phototherapy would significantly increase over the next couple of years in places like North America and Europe. The North America and Europe phototherapy treatment market revenue is anticipated to increase at a CAGR of 6.0% over the projected period, according to a recent study from Future Market Insights (2017–2027).

Download Now: Explore the Booming Phototherapy Treatment Market with Our Sample Report! @ https://www.futuremarketinsights.com/reports/sample/rep-gb-na-4297

Early beginning of acne in youngsters is associated with distorted eating patterns as well as excessive consumption of fried and ready-to-eat food products. Women also experience the emergence of severe acne and psoriasis as adults. The most lucrative market for phototherapy is North America, followed by Western Europe and Eastern Europe, according to a report titled “Phototherapy Treatment Market for Acne and Psoriasis North America and Europe Industry Analysis 2012 – 2016 and Opportunity Assessment; 2017 – 2027.” According to projections, the North American market would increase from US$ 594.5 Mn in 2016 to US$ 1,150.0 Mn by the end of 2027. Additionally, the U.S. currently controls more than three-fourths of the market for phototherapy treatments in North America.

Increasing adoption of phototherapy in dermatology clinics and hospitals in Europe is favouring the growth of the market in the region. Moreover, psychological burdens associated with acne and psoriasis is high in the region, compelling patients to seek professional help in the form of prescription treatments, phototherapy, and others. Germany and the UK are two of the major markets for phototherapy in Europe and expected to remain dominant throughout the forecast period.

Key Excerpts from the Report Include:

• Based on end user, hospitals currently account for the largest value share of the phototherapy treatment market for acne and psoriasis in North America and Europe. However, preference for home care settings among patients is likely to grow in the near future.
• Demand for blue light therapy is relatively higher than other phototherapy types in both North America and Europe. This trend is expected to continue throughout the assessment period. The blue light phototherapy segment is estimated to reach a market valuation of US$ 1,067.1 Mn towards the end of 2027.

Unlock the Power of Expert Advice with Ask the Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-na-4297

Phototherapy being a high margin reconstructive technology is perceived as an opportunity for market players to invest in future growth.

• Lifespan,
• UC Irvine Health,
• Buffalo Medical Group,
• Blackrock Clinic Limited,
• The Private Phototherapy Clinic Ltd,
• National Skin Centre,
• and Massachusetts General Hospital

North America and Europe Phototherapy Treatment for Acne and Psoriasis Market – Taxonomy

By Disease Type

• Psoriasis
  • Guttate Psoriasis
  • Inverse Psoriasis
  • Pustular Psoriasis
  • Erythrodermic Psoriasis
  • Plaque Psoriasis
• Acne
  • Acne Vulgaris
  • Acne Conglobata
  • Acne Fulminans
  • Gram-Negative Folliculitis
  • Acne Rosacea
  • Pyoderma Faciale

Unlock Exquisite Customization and Save up to 30%: Your Path to Personalized Perfection. @ https://www.futuremarketinsights.com/customization-available/rep-gb-na-4297

By Phototherapy Type

• Blue Light Phototherapy
• Red Light Phototherapy
• Intense Pulsed Light (IPL) Phototherapy
• Narrowband UVB Phototherapy
• Psoralens+Ultravioletlight A (PUVA) Phototherapy

By End User

• Hospitals
• Dermatology Clinics/Skin Care Centres
• Wellness Centres
• Home Care Settings

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 4-years.

Contact Us:          

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube